- Patent Title: Estrogen receptor ligand treatment for neurodegenerative diseases
-
Application No.: US15507881Application Date: 2015-09-01
-
Publication No.: US10758496B2Publication Date: 2020-09-01
- Inventor: Rhonda R. Voskuhl
- Applicant: The Regents of the University of California
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Foley Hoag LLP
- Agent David P. Halstead; Alexander J. Chatterley
- International Application: PCT/US2015/047909 WO 20150901
- International Announcement: WO2016/036721 WO 20160310
- Main IPC: A61K31/05
- IPC: A61K31/05 ; C07D307/93 ; C07D487/04 ; C07D307/82 ; A61K31/137 ; A61K31/225 ; C07C39/42 ; A61K38/13 ; A61K38/21 ; A61K45/06
Abstract:
The present invention relates to treatment of neurological diseases such as multiple sclerosis (MS) and Alzheimer's disease, using an estrogen receptor beta (ERβ) ligand.
Public/Granted literature
- US20170304216A1 ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES Public/Granted day:2017-10-26
Information query
